Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer

By Nikita Chaurasia  | Date: 2020-09-21

Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer

Innovent Biologics Inc., in collaboration with American pharmaceutical giant Eli Lilly and Company, have reportedly announced that the biomarker results of ORIENT-11 trials which were displayed during a mini verbal presentation at ESMO (European Society for Medical Oncology) Virtual Congress 2020.

As per the credible sources, ORIENT-11 is a phase 3 clinical trial that evaluates TYVYT® combined with ALIMTA® and platinum chemotherapy as a cure for recurrent or advanced nonsquamous non-small cell lung cancer without modifying ALK rearrangements or EGFR mutations.

In fact, the NMPA (National Medical Products Administration) of China has already approved the supplemental New Drug Application (sNDA) for this indication.

If sources are to be believed, data analysis on biomarker showed that MHC-II antigen presentation pathway has played a major role in immunotherapy-chemotherapy combination. Additionally, higher gene expression of this route can serve as a predictive biomarker which allows individuals to choose for whom this regimen can be beneficial.

Head of Department of Internal Medicine at Sun Yat-sen University Cancer Center as well as the primary investigator of the ORIENT-11 trials, Professor Li ZHANG, reportedly stated that there is improvement in efficiency when Sintilimab is combined with pemetrexed and platinum chemotherapy. He further added that there are no newly detected safety signals in nonsquamous metastatic or locally advanced NSCLC.

Dr. Li Wang, Senior VP at Lilly China as well as the Head of Lilly China Drug Development and Medical Affairs Center, claimed that exploring the use of biomarkers helps in effectively understanding cancer immunotherapy.  She further mentioned that the company is thrilled about the results and is looking forward to presenting the results at ESMO.

Reportedly, the primary results on the research were declared in IASLC World Conference on Lung Cancer (WCLC) 2020 Virtual Presidential Symposium in a presentation held verbally and were published by Journal of Thoracic Oncology.

Source credits-

https://www.benzinga.com/pressreleases/20/09/n17577448/innovent-and-lilly-release-biomarker-results-of-tyvyt-sintilimab-injection-in-combination-with-ali

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More >>

More News By Nikita Chaurasia

ZeroAvia buys HyPoint to strengthen hydrogen fuel-cell technology offering

ZeroAvia buys HyPoint to strengthen hydrogen fuel-cell technology offering

By Nikita Chaurasia

British/American hydrogen-electric aircraft developer, ZeroAvia has wholly purchased HyPoint, a hydrogen fuel cell system provider, to strengthen its hydrogen-electric product portfolio. As per sources, ZeroAvia is developing powertrains for hydro...

Chanel pioneers ¬sustainability-linked bonds for combating climate changes

Chanel pioneers ¬sustainability-linked bonds for combating climate changes

By Nikita Chaurasia

French luxury fashion house well-recognized for its perfumes and tweed suits, Chanel, has reportedly unveiled ­sustainability-linked bonds, or SLBs, to combat climate change two years ago when the firm was in need to borrow money. The investor...

NLP Logix Partners and Databricks team up for Lakehouse Platform

NLP Logix Partners and Databricks team up for Lakehouse Platform

By Nikita Chaurasia

NLP Logix, a well-known predictive modeling and machine learning leader, has recently announced that it has entered into a partnership with Databricks, an American enterprise software company, to drive business value by deploying data and artificial ...

Elliptic Labs inks deal with Xiaomi to offer a proximity detection solution

Elliptic Labs inks deal with Xiaomi to offer a proximity detection solution

By Nikita Chaurasia

Elliptic Labs, a global AI software company, has reportedly entered into a new agreement with Xiaomi, one of the third-largest smartphone manufacturers across the globe. With this agreement, Xiaomi will continue to leverage INNER BEAUTY, the AI Vi...

L&T Technology Services partners with Qualcomm to amplify 5G adoption

L&T Technology Services partners with Qualcomm to amplify 5G adoption

By Nikita Chaurasia

L&T Technology Services Limited has recently announced that it is teaming up with Qualcomm Technologies, Inc., the world’s leading wireless technology innovator. With the latest collaboration, the firm plans to offer end-to-end solutions...